The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Download
Download White Paper
Related Solutions
Clinical
CMC Strategy & Development
Discovery Sciences
Medical Writing
Regulatory Strategy
Scientific, Regulatory & Quality
Technical Operations & Delivery Infrastructure
Biologics
Cell & Gene Therapy
Discovery
Emerging & Early-Stage Biotech
For Private Equity & Investors
Mid-Sized to Large Enterprise Biopharma
Preclinical
Small Molecule
Related Resources
All Resources
Let's move from science to success.
Let’s Talk